Okres ważności: 

Shelf life of the kit is 1 year.
The radiolabelled product should be administered within 5 hours of preparation. Radiochemical purity and stability data of preparation refer to this time at a temperature below 25°C.

Warunki przechowywania: 

Store in a refrigerator (2°C- 8°C).
During transportation (not longer than 7 days) up to 35°C.
Expiry date is given on the label.
Shelf life after reconstitution and labelling with sodium pertechnetate (99mTc) solution:
up to 5 hours at a temperature below 25°C in a suitable radiation lead shield.
Storage should be in accordance with national regulations for radioactive materials. 

Postać farmaceutyczna: 

Kit for radiopharmaceutical preparation.
Lyophilisate for solution for injection.

Skład jakościowy i ilościowy substancji czynnych: 

1 vial contains:
N-[2,4,6-trimethyl-3-bromacetanilid]iminodiacetic acid sodium salt   20 mg

Wykaz substancji pomocniczych: 

Stannous chloride dihydrate

Rodzaj i zawartość opakowania: 

10 ml multi-dose glass vials sealed with a  rubber stopper and aluminium cap in cardboard box.
3 vials
6 vials

Wskazania do stosowania: 

The radiopharmaceutical 99mTc-MBrIDA is indicated for diagnostics of hepatobiliary tract patency and for differentiation of jaundice. It is used for imaging of hepatobiliary system, especially at reduced hepatic function and high bilirubin levels. Cholescintigraphy may be performed even at serum bilirubin levels higher than 5 mg%. The radiopharmaceutical is used in diagnostics of hepatitis, hepatic duct occlusion, gallbladder functional disorders, inflammation of the hepatobiliary system, cholecystitis with occlusion of the cystic duct and other hepatic and hepatobiliary system pathologies. The radiopharmaceutical may be used for detection of intrahepatic cholestasis in order to differentiate it from other hepatobiliary diseases, which involve hepatocyte damage.



Nasza siedziba